Cargando…
Long-Term Use of Intravitreal Bevacizumab (Avastin) for the Treatment of Von Hippel-Lindau Associated Retinal Hemangioblastomas
Retinal hemangioblastomas are the most common manifestation of Von Hippel-Lindau (VHL) disease [1-3]. While peripheral retinal hemangioblastomas may be treated by thermal laser treatment or cryotherapy, optic nerve and macular lesions are more difficult to treat [4, 5]. Based on the theoretical bene...
Autores principales: | Hrisomalos, Frank N, Maturi, Raj K., Pata, Veena |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032222/ https://www.ncbi.nlm.nih.gov/pubmed/21293730 http://dx.doi.org/10.2174/1874364101004010066 |
Ejemplares similares
-
Von Hippel-Lindau Disease: The Importance of Retinal Hemangioblastomas in Diagnosis
por: Şahin Atik, Sevinç, et al.
Publicado: (2017) -
Resection of von Hippel Lindau Related Brainstem Hemangioblastoma
por: Maggio, Dominic, et al.
Publicado: (2019) -
Verteporfin photodynamic therapy of retinal capillary hemangioblastoma in von Hippel-Lindau disease
por: Bhattacharjee, Harsha, et al.
Publicado: (2010) -
Retinal capillary hemangioblastoma associated with retinochoroidal coloboma in Von Hippel-Lindau disease
por: Mishra, Priyadarshini, et al.
Publicado: (2019) -
Von Hippel-Lindau Syndrome: Diagnosis and Management of Hemangioblastoma and Pheochromocytoma
por: Vaganovs, P., et al.
Publicado: (2013)